| GC35309-10mg |
|
51876-97-2 |
|
0 |
C14H8NNaO4 |
|
|
|
| GC35309-5mg |
|
51876-97-2 |
|
0 |
C14H8NNaO4 |
|
|
|
| GC35308-5mg |
|
36052-37-6 |
|
0 |
C16H14O4 |
|
|
|
| GC35307-5mg |
|
20318-30-3 |
|
0 |
C45H73NO16 |
|
|
|
| GC35306-100mg |
|
1 |
|
0 |
C24H26O6 |
|
|
|
| GC35306-50mg |
|
1 |
|
0 |
C24H26O6 |
|
|
|
| GC35306-25mg |
|
1 |
|
0 |
C24H26O6 |
|
|
|
| GC35306-10mg |
|
1 |
|
0 |
C24H26O6 |
|
|
|
| GC35306-10mM (in 1mL DMSO) |
|
1 |
|
0 |
C24H26O6 |
|
|
|
| GC35303-10mg |
|
1189919-71-8 |
Alosetron D3 Hydrochloride
|
0 |
C17H16D3ClN4O |
|
|
|
| GC35303-5mg |
|
1189919-71-8 |
Alosetron D3 Hydrochloride
|
0 |
C17H16D3ClN4O |
|
|
|
| GC35303-1mg |
|
1189919-71-8 |
Alosetron D3 Hydrochloride
|
0 |
C17H16D3ClN4O |
|
|
|
| GC35302-50mg |
|
132414-02-9 |
Alosetron (Hydrochloride(1:X))
|
0 |
C17H18N4O.xHCl |
|
|
|
| GC35302-10mg |
|
132414-02-9 |
Alosetron (Hydrochloride(1:X))
|
0 |
C17H18N4O.xHCl |
|
|
|
| GC35301-50mg |
|
122852-43-1 |
Alosetron ((Z)-2-butenedioate)
|
0 |
C21H22N4O5 |
|
|
|
| GC35301-10mg |
|
122852-43-1 |
Alosetron ((Z)-2-butenedioate)
|
0 |
C21H22N4O5 |
|
|
|
| GC35299-5mg |
|
105317-67-7 |
|
0 |
C29H32O11 |
|
|
|
| GC35299-1mg |
|
105317-67-7 |
|
0 |
C29H32O11 |
|
|
|
| GC35298-5mg |
|
33037-46-6 |
Aloe-emodin-8-O-β-D-glucopyranoside
|
0 |
C21H20O10 |
|
|
|
| GC35297-100mg |
|
1637771-14-2 |
|
0 |
C26H23N5O2 |
|
|
|
